Glycomimetics Inc (GLYC)

Last Year

23-Nov-23 -- 22-Nov-24

Time Period:

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Biotechnology

Drugs

Insider Trading Sentiment: Strong Sell

Insider Trading Sentiment: Strong Buy

Sentiment Breakdown by Insider

0

(3)

0

(2)

1

(1)

19

0

5

+1

0

+2

0

+3

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
02-Apr-24 4:05 PM View:	29-Mar-24 Grant $13.75K	Goldberg Mark Alan Director		Glycomimetics Inc - GLYC	40% 25.91K to 36.33K	0	0	--	--	Show Txns Hide Txns

02-Apr-24 4:05 PM View:	29-Mar-24 Grant $15.63K	Junius Daniel M Director		Glycomimetics Inc - GLYC	6% 93.25K to 98.46K	0	0	--	--	Show Txns Hide Txns

02-Jan-24 4:05 PM View:	29-Dec-23 Grant $12.25K	Andrews Patricia S Director		Glycomimetics Inc - GLYC	10% 53.42K to 58.61K	0	0	--	--	Show Txns Hide Txns

20-Jun-24 4:15 PM View:	18-Jun-24 Private Purchase $4.33K	Hahn Brian M. SVP Finance, CFO		Glycomimetics Inc - GLYC	33% 53.14K to 70.64K	0	0	--	--	Show Txns Hide Txns

02-Apr-24 4:05 PM View:	29-Mar-24 Grant $10.00K	King Rachel K. Director		Glycomimetics Inc - GLYC	1% 653.26K to 659.1K	0	0	--	--	Show Txns Hide Txns

24-Jun-24 4:29 PM View:	21-Jun-24 Purchase $30.72K	Rock Edwin Chief Medical Officer		Glycomimetics Inc - GLYC	81% 375.4K to 680.4K	0	0	--	--	Show Txns Hide Txns

09-Aug-24 4:30 PM View:	08-Aug-24 Sale ($50.01K)	Invus Public Equities, Lp 10% Owner		Glycomimetics Inc - GLYC	(26%) 8.59M to 6.32M	0	0	--	--	Show Txns Hide Txns